Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-154212

Chief Executive Officer sold 7,200 shares at an average $17.93 ($129,060)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-12-06 Sale : show line 1 in the form −3,600 $18.55 $66,780 381,378 I
2016-12-07 Sale : show line 2 in the form −3,600 $17.30 $62,280 377,778 I
Open-market sales · 7,200 sh · avg $17.93 · $129,060
Loading xslF345X03/doc4.xml…